Orly Ardon, PhD

Associate Attending Imaging Scientist, Surgical Pathology Service; Director of Digital Pathology Operations
Orly Ardon

As Director of Digital Pathology Operations, I lead clinical digital pathology at MSK, one of the largest digital pathology operations in the world. I serve on the board of directors of the Digital Pathology Associations (DPA) and on the DPA membership and patient engagement committees.

Under my leadership, the digital pathology service grew from a small retrospective scanning operation to a large 24/7 operation that allows the prospective digitization of all the institution’s pathology slides. This scanning infrastructure allows the availability of digitized images for educational, research, and clinical applications, and the development of computational decision support tools for pathology.

Before joining MSK, I led the development of novel computer-assisted diagnostic tools and the expansion of digital pathology collaborative initiatives at ARUP Laboratories in Salt Lake City, Utah and was an adjunct associate professor at the University of Utah.

My academic and translational research experience includes laboratory research and test development in microbiology, genetics, biochemistry, immunology, and genomics as well as the business aspects of clinical laboratories and healthcare.

My research focus is on digital imaging, quality laboratory operations, new digital pathology solutions and the integration of Artificial Intelligence (AI) based tools to pathology operations. My interests also include laboratory automation, process improvement, healthcare economics and digital health.

Clinical Expertise

Digital Pathology Imaging

Education

BSc, MSc, PhD, The Hebrew University of Jerusalem; Executive MBA, University of Utah

Publications

1.   Ardon, O., Schmidt, RL. (2020) Cinical Laboratory Employees’ Attitudes Towards Artificial Intelligence. Lab Med. 51(6):649-654 doi: 10.1093/labmed/lmaa023

2.   Ardon, O., Reuter, V.E., Hameed, M., Corsale, L. Manzo, A., Sirintrapun, S.J., Ntiamoah, P., Schüffler, P.J., England, C., Klimstra D.S., Hanna, M.G. 2021 Digital Pathology Operations at a NYC Tertiary Cancer Center During the First 4 Months of COVID-19 Pandemic Response. Acad Pathol 8: January 2021 doi:10.1177/23742895211010276

3.   Hanna, M.G., Ardon, O., Reuter, V.E., Sirintrapun, S.J., England, C., Klimstra, D., Hameed, M. (2022) Integrating digital pathology into clinical practice. Mod Pathol 35:152 – 164. doi 10.1038/s41379-021-00929-0

4.   Ardon, O., Klein, E., Manzo, A., Corsale, L. England, C., Mazzella, A., Geneslaw, L., Philip, J., Ntiamoah, P., Wright, J., Sirintrapun, S.J., Lin, O., Elenitoba-Johnson, K., Reuter, V.E., Hameed, M.P., Hanna, M.G. (2023) Digital Pathology Operations at a Tertiary Cancer Center: Infrastructure Requirements and Operational Cost. J Pathol Inform 14: 100318. https://doi.org/10.1016/j.jpi.2023.100318.

5.   Ardon, O., Labasin, M, Friedlander, M., Manzo, A., Corsale, L., Ntiamoah, P., Wright, J., Elenitoba-Johnson, K., Reuter, V.E., Hameed, M.P., Hanna, M.G. (2023) Quality Management System in Clinical Digital Pathology Operations at a Tertiary Cancer Center. Laboratory Investigation. Volume 103, Issue 11, November 2023, 100246. https://doi.org/10.1016/j.labinv.2023.100246. 

6. Ardon, O., Asa, S.L., Lloyd, M.C., Lujan, J., Parwani, A., Santa-Rosario, J.C., Van Meter, B. Samboy, J., Pirain, D., Blakely, S., Van Meter, B., Hanna, M.G. (2024) Understanding the Financial Aspects of Digital Pathology: A Dynamic Customizable Return on Investment Calculator for Informed Decision-Making. J Pathol Inform DOI:10.1016/j.jpi.2024.100376.

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Orly Ardon discloses the following relationships and financial interests:

  • Hamamatsu Photonics K.K.
    Professional Services and Activities
  • Leica Biosystems
    Professional Services and Activities
  • Techcyte, Inc.
    Equity; Professional Services and Activities (Uncompensated)

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures